Podcasts about section head

Part 1 of the Faces of the Industry award winners, reflecting a simple philosophy: the electricity sector isn't made up of companies—it's made up of people. In conversation with Francis Bradley, this year's winners showcase the creativity, innovation, leadership and grace under pressure that make Canada's electricity system. The winners on this episode are Sandra Haskins, Senior Vice President and CFO at Capital Power, Joy Brake, Senior Technical Advisor, System Planning at Nova Scotia Power, and Jeffrey Laninga, Live Line Engineer and Section Head at Manitoba Hydro.Link:Read the Faces of the Industry press release on the Electricity Canada website.

Send us a textThis week we have a couple of great Local interviews! Ochsner Children's Hospital has been one of our anchoring sponsors for years now and for our fifth season, We have created a BRAND NEW SEGMENT called         "A Mother's Giving: & the Milk Bank of Louisiana with Dr. Harley Ginsberg."Dr. Ginsberg is board certified in both pediatrics and neonatal-perinatal medicine and has been on staff at Ochsner since 1987. He served as both the Section Head of neonatal medicine at Ochsner and the Medical Director of the neonatal intensive care unit (NICU) at Ochsner Baptist Medical Center from 1989 until 2021. Dr. Ginsberg managed the team at Ochsner that took care of babies during Hurricane Katrina. Currently he is Medical Director of the NICU at Ochsner Kenner Medical Center. Dr. Ginsberg is the Founder and Medical Director of Mothers Milk Bank of Louisiana at Ochsner Baptist and is a member of the Standards Committee for the Human Milk Banking Association of North America. He has written chapters for medical textbooks on neonatology and has published scientific medical in articles in the New England Journal of Medicine, Pediatrics, Journal of Perinatology and Clinics in Perinatology. Fully accredited by the Human Milk Banking Association of North America, Mothers' Milk Bank of Louisiana at Ochsner Baptist was Louisiana's first human milk bank and the 24th nonprofit milk bank in the United States. Preterm infants are at risk for a condition called necrotizing enterocolitis, which results in inflamed intestines, bacterial infection and damage to the colon and intestines. Without proper care, the infant may die.Pasteurized donor human milk helps offset these potential dangers. Unfortunately, some mothers of preterm infants cannot produce their own milk. That's where Mothers' Milk Bank of Louisiana steps in.As of August 2020, Louisiana provides Medicaid coverage for using pasteurized donor human milk in a hospital. In 2022, Louisiana legislators approved inpatient and outpatient coverage for pasteurized donor human milk. Listen as Dr. Ginsberg and I dive into the Milk bank of Louisiana and hear the powerful impacts it has on our community and state! Go to https://www.ochsner.org/services/mothers-milk-bank-at-ochsner-baptist to learn more or to make a donation today!______________________________________________________________________________________________Then later we welcome back DIRTY DOGS! The local documentary making big waves in our city yall. Not only did the documentary chronicle the heated monopoly on New Orleans' food cart licenses for the French Quarter. What WAS a half century monopoly was essentially ended by a group of passionate film makers that felt convicted to MAKE THINGS RIGHT.  I am so excited to welcome restauranteur and host Brad Bohannan and Cinematographer, Adrian Sosebee to talk about their HOLLYWOOD AWARD they just received in  Beverly Hills! Brad also talks to us about his latest venture with his inspirational wife, Jefferson Parrish Council Person, Arita Bohannan. Together and with a village behind them, they work to bring inclusive and autistic friendly playgrounds to neighborhoods and communities tThank you to our family of amazing sponsors! Ochsner Hospital for ChildrenWww.ochsner.orgRouses MarkersWww.rousesmarkets.comSandpiper VacationsWww..sandpipervacations.comCafe Du Monde www.shop.cafedumonde.com The Law Firm of Forrest Cressy & James Www.forrestcressyjames.comComfort Cases Www.comfortcases.orgNew Orleans Ice Cream CompanyWww.neworleansicecream.comERA TOP REALTY: Pamela BreauxAudubon Institute www.auduboninstitute.orgUrban South Brewery www.urbansouthbrewery.com

Join Dr. Matt Nielsen, Chair of AUA's Science and Quality Council and Chair of the Department of Urology at University of North Carolina Chapel Hill as he speaks with Dr. Andrei Purysko, Section Head of Abdominal Imaging at the Cleveland Clinic and Physician Leader of the American College of Radiology's Prostate MR Image Quality Improvement Collaborative, on improving the diagnosis of clinically significant prostate cancer with the use of high-quality prostate MR images. For additional information, please visit AUAnet.org/QISummit.

It is a Reboot Special with one of our faves - Dr. Brian Cole!Today's episode is going to focus on osteochondral allograft transplantation, and specifically how basic science research can and should impact your clinical practice.We are joined today by Dr. Brian Cole, a Professor of Orthopedic Surgery and Chair of the Department of Orthopedic Surgery at Rush University Medical Center, Chair of Surgery at Rush Oak Park Hospital and Section Head of the Rush Cartilage Restoration Center.  He is also a past president of the Arthroscopy Association of North America and a team physician for the Chicago Bulls and Chicago White Sox.

Anita W. Asgar, MD, recently named section head of Interventional Cardiology at Northwestern Medicine, introduces herself and reveals what drew her to join the team at Northwestern Medicine Bluhm Cardiovascular Institute. Dr. Asgar shares her goals for the future of the Interventional Cardiology program, her clinical and research interests in structural heart interventions and moderate secondary mitral regurgitation, and her experience working on MitraClip procedures in Canada.

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1 fusions are rare but important events seen in many cancer types, including NSCLC. Zenocutuzumab is a HER2/HER3 bispecific antibody that showed clear efficacy in NSCLC and in pancreatic cancer that harbored an NRG1 fusion. Guest: Dr. Alison Schram, Assistant Attending Physician and Section Head of Oral Therapeutics in Early Drug Development at Memorial Sloan Kettering Cancer Center in New York

In this engaging episode of The Life of Flow Podcast, we welcome Dr. Constantino Peña, Section Head of Interventional Radiology at the Miami Cardiac and Vascular Institute. Dr. Peña shares insights into his extensive work in Latin America, the collaborative spirit in advancing vascular care, and his involvement in transformative conferences like the ISET meeting.The conversation spans from reminiscing about pivotal moments in vascular care to discussing the evolution of medical education, the integration of cutting-edge technologies, and the challenges of democratizing healthcare tools globally. Dr. Peña's stories of ingenuity and perseverance highlight the creativity required to overcome resource limitations, making this episode both inspiring and educational.Key Topics Discussed:The Latin American Impact:The profound influence of Latin American collaborations on global vascular care.How regional expertise is shaping global practices.Transforming Medical Conferences:The legacy and future of the ISET meeting.The importance of live case demonstrations and interactive learning.Innovation in Challenging Environments:Stories of resourceful medical practices in underserved regions.Local development of medical devices in Brazil and Mexico.Future Frontiers:The role of AI in education and patient care.Decentralizing healthcare systems and creating integrated networks for accessible care.Takeaways from Dr. Peña:Collaboration and innovation are key to advancing medical care, even in resource-limited settings.Conferences and meetings should adapt to modern learning styles, focusing on nuanced discussions and cutting-edge technologies.A vision for a decentralized, accessible healthcare model that integrates hospitals, outpatient centers, and communities.

This presentation outlines adversarial command and control attacks in OT networks.  Focusing on the electrical grid, this presentation highlights current gaps in critical infrastructure protection research.  After discussing real-world examples, a fictional electrical grid is used to explore cyber-physical threats and mitigations to OT systems. About the speaker: Dr. Mason Rice is the director of the Cyber Resilience and Intelligence Division at Oak Ridge National Laboratory. In this role, he is responsible for an R&D portfolio focused on advanced intelligent systems and resilient cyber-physical systems, including research into (1) AI for national security, (2) cybersecurity for critical systems, (3) machine-augmented intelligence, (4) vulnerability science, and (5) identity science.Following retirement from the Army, Dr. Rice joined ORNL in 2017 as the Cyber-Physical R&D Manager and was soon appointed as the first Group Leader for Resilient Cyber-Physical Systems at ORNL. He ultimately grew the group into four focused research groups, at which point he was selected to be the first Section Head of the new Resilient Cyber-Physical Systems Section.

The following question refers to Sections 7.4 and 7.5 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by the Director of the CardioNerds Internship Dr. Akiva Rosenzveig, answered first by Vanderbilt AHFT cardiology fellow Dr. Jenna Skowronski, and then by expert faculty Dr. Randall Starling.Dr. Starling is Professor of Medicine and an advanced heart failure and transplant cardiologist at the Cleveland Clinic where he was formerly the Section Head of Heart Failure, Vice Chairman of Cardiovascular Medicine, and member of the Cleveland Clinic Board of Governors. Dr. Starling is also Past President of the Heart Failure Society of America in 2018-2019. Dr. Staring was among the earliest CardioNerds faculty guests and has since been a valuable source of mentorship and inspiration. Dr. Starling's sponsorship and support was instrumental in the origins of the CardioNerds Clinical Trials Program.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. American Heart Association's Scientific Sessions 2024As heard in this episode, the American Heart Association's Scientific Sessions 2024 is coming up November 16-18 in Chicago, Illinois at McCormick Place Convention Center. Come a day early for Pre-Sessions Symposia, Early Career content, QCOR programming and the International Symposium on November 15. It's a special year you won't want to miss for the premier event for advancements in cardiovascular science and medicine as AHA celebrates its 100th birthday. Registration is now open, secure your spot here!When registering, use code NERDS and if you're among the first 20 to sign up, you'll receive a free 1-year AHA Professional Membership! Question #38 Mrs. M is a 65-year-old woman with non-ischemic dilated cardiomyopathy (LVEF 40%) and moderate to severe mitral regurgitation (MR) presenting for outpatient follow-up. Despite improvement overall, she continues to experience dyspnea on exertion with two flights of stairs and occasional PND. She reports adherence with her medication regimen of sacubitril-valsartan 97-103mg twice daily, metoprolol succinate 200mg daily, spironolactone 25mg daily, empagliflozin 10mg daily, and furosemide 80mg daily. A transthoracic echocardiogram today shows an LVEF of 35%, an LVESD of 60 mm, severe MR with a regurgitant fraction of 60%, and an estimated right ventricular systolic pressure of 40 mmHg. Her EKG shows normal sinus rhythm at 65 bpm and a QRS complex width of 100 ms. What is the most appropriate recommendation for management of her heart failure?AContinue maximally tolerated GDMT; no other changesBRefer for cardiac resynchronization therapy (CRT)CRefer for transcatheter mitral valve intervention Answer #38 ExplanationChoice C is correct. The 2020 ACC/AHA Guidelines for the management of patients with valvular heart disease outline specific recommendations.In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF

On this episode of Defence Deconstructed, Dr. Alexander Salt speaks to Cdr Gray, LCol Couillard, LCol Luhning, LCol Peitzsche, and Maj Gaulthier about their services' approach to AI Adoption. This episode is from Triple Helix' October 29, 2024 roundtable on AI adoption within the Canadian Armed Forces. It was made possible thanks to the Department of National Defence's MINDS program, CGAI's strategic sponsors Lockheed Martin Canada, General Dynamics, Hanwha Defence and Ocean, and our roundtable sponsor L3Harris Technologies. Defence Deconstructed is brought to you by Irving Shipbuilding. • Cdr Gray, Section Head, Naval Innovation, RCN • LCol Couillard, J6, CANSOFCOM • Col Luhning, Director, Digital and Army Combat System Integration, Canadian Army • LCol Peitzsche, C4ISR Requirement Analysis Section Head, RCAF • Dr. Alexander Salt, Post-Doctoral Fellow, Triple Helix Music Credits: Drew Philipps. Producer: Charlotte Duval-Lantoine

Section Head of Surgical Sleep and Snoring Alan Kominsky, MD provides a deep dive into the evolution of surgical sleep therapy, including soft tissue surgery, to the current gold standard of hypoglossal nerve stimulation, to more innovations on the horizon.

Can you imagine a team of detectives tirelessly working around the clock to solve mysteries that affect public health?  On today's podcast we're shedding light on foodborne illness investigations in a guest podcast episode from Inspect and Protect, the Canadian Food Inspection Agency's podcast with hosts Michelle Strong and Greg Rogers. Today's expert panel of guests includes Tanis Kershaw and Courtney Smith from the Public Health Agency of Canada's Outbreak Management Division, Fred Jamieson, the Food Safety Recall Specialist in the Food Safety Investigation Recall Unit, and Angela Catford, Section Head of Health Risk Assessment at Health Canada. From identifying outbreaks to tracing contaminated foods, their work is essential in safeguarding our health. Stay with us as we explore how these experts collaborate during outbreaks, from initial detection to risk assessment and more. Guest Episode  Inspect and Protect is the official podcast of the Canadian Food Inspection Agency with a focus on sharing stories about safe food, healthy animals and disease and pest-free plants. Bios:Greg Rogers Greg Rogers is the Communications Manager for the four Atlantic provinces at the Canadian Food Inspection Agency. He also co-hosts “Inspect and Protect”, the CFIA's official podcast all about food safety, plant and animal health. He is based in Moncton, New Brunswick. Michelle Strong Michelle Strong is Senior Communications Advisor for Animal Health Programs for the Canadian Food Inspection Agency. She is also co-host for “Inspect and Protect”, the CFIA's official podcast all about food safety, plant and animal health. She lives in Ottawa, Ontario. Tanis Kershaw  Tanis Kershaw is an acting manager with the Outbreak Management Division at the Public Health Agency of Canada. Experienced Epidemiologist with a demonstrated history of working in local, provincial, federal and international levels of public health over the past 17 years. Skilled in outbreak detection and investigation, surveillance, data analysis and research. Courtney Smith Courtney Smith is a senior epidemiologist and works alongside the Outbreak Management Division at the Public Health Agency of Canada.  Fred Jamieson Fred Jamison is the Food Safety Recall Specialist with the Office of Food Safety Recall in the Food Safety Investigation Recall Unit.  Angela Catford Angela Catford is the Section Head of the Health Risk Assessment Section at Health Canada. Resources Subscribe to food recalls and alerts Find out where to report a food complaint or concern How we decide to recall a food product Investigating outbreaks of foodborne illnessConnect with us: Website, Facebook, Twitter, Instagram, Youtube , emailSign up for our newsletter

On today's episode we're focusing on biologic augmentation of rotator cuff tears – including an algorithm for determining which patients require augmentation as well as different augmentation approaches such as extracellular matrix scaffolds and Orthobiologics.   We are joined today by Dr. Brian Cole, a Professor of Orthopedic Surgery and Chair of the Department of Orthopedic Surgery at Rush University Medical Center, Chair of Surgery at Rush Oak Park Hospital and Section Head of the Rush Cartilage Restoration Center.  He is also a past president of the Arthroscopy Association of North America and a team physician for the Chicago Bulls and Chicago White Sox.Research Links:https://www.briancolemd.com/wp-content/themes/ypo-theme/pdf/rotator-cuff-augmentation-with-dermal-allograft-improve-clinical-outcomes.pdfhttps://www.briancolemd.com/wp-content/themes/ypo-theme/pdf/bmac-augmentation-may-produce-structurally-superior-rotator-cuff-repair-2023.pdfhttps://pubmed.ncbi.nlm.nih.gov/32169466/CuffMend: https://www.arthrex.com/shoulder/cuffmend-augmentation-system

Over the last few decades, the roles of nurse practitioners (NPs) and physician assistants (PAs), also known as advanced practice providers (APPs), have greatly expanded to touch even more patient-family lives. They are an essential part of the care we provide, and their roles have evolved over time. In this episode, we explore the crucial part they play in our medical system and how that might continue to evolve in the future. For this episode, we are joined by two University of Colorado leaders who continue to help keep our APP programs among the top ranked in the country. Jonathan Bowser is the Child Health Associate and Physician Assistant Program Director at the University of Colorado School of Medicine. He is also the Associate Dean of Physician Assistant Studies, the Section Head of Pediatrics, and an associate professor. Jill Marks, NP, is the Specialty Director of the Acute Care Pediatric Nurse Practitioner Program at the University of Colorado College of Nursing. She is also an inpatient nurse practitioner for the section of pediatric neurology at the University of Colorado School of Medicine. Some highlights from this episode include:  Background on the creation of NPs and PAs  The ways these roles have changed over time  The impact APPs make on patient care  The role APPs will play in healthcare in the future  For more information on Children's Colorado, visit: childrenscolorado.org.    

Today's episode is going to focus on osteochondral allograft transplantation, and specifically how basic science research can and should impact your clinical practice.We are joined today by Dr. Brian Cole, a Professor of Orthopedic Surgery and Chair of the Department of Orthopedic Surgery at Rush University Medical Center, Chair of Surgery at Rush Oak Park Hospital and Section Head of the Rush Cartilage Restoration Center.  He is also a past president of the Arthroscopy Association of North America and a team physician for the Chicago Bulls and Chicago White Sox. So, without further ado, let's get to the Field House!

Quantum computers can already complete calculations that would take current computers millions of years to solve, and experts say that researchers are on track to cross a game-changing threshold in this new technology by 2030. MTSU recently launched its Quantum Science Initiative and is working with regional partners, including Oak Ridge National Laboratory, to educate and train students here in Middle Tennessee to step into research and technical jobs in this emerging field. Today, we're speaking with students and researchers about their work — and what we all need to know about what many are calling a revolutionary technology.GUESTS Dr. Hanna Terletska, Associate professor, MTSU's  Physics and Astronomy Department, head of MTSU's Quantum Science Initiative Ariel Nicastro,  Rising junior at MTSU Adetoro Akinola, Rising junior at Fisk University Dr. Stephen Jesse, Oak Ridge National Laboratory, Section Head of Nanomaterials Characterization at the CNMS

Welcome to the 158th episode of the Tooth or Dare Podcast with Irene Iancu (@toothlife.irene) and this week's guest Dr. Effrat (Effie) Habsha (@effiehabsha).  In Part 2 of this interview with Dr. Habsha, we learn about how she started Women in Dentistry, an organization dedicated to supporting female dental professionals in a traditionally male-dominated industry. They offer continuing education, mentorship, and in-person events to help members improve their clinical skills, manage work-life balance, and connect with like-minded peers. Listen to the full episode to learn more about the benefits and how to join Women in Dentistry. Effrat (Effie) Habsha, BSc, DDS, Dip. Prostho., MSc, FRCDC Dr. Effie Habsha is the Founder of Women in Dentistry: Work. Life. Balance.  She received her Bachelor of Science degree and earned her DDS degree from the University of Toronto. Upon graduation, she completed a one-year General Practice Residency at Mount Sinai Hospital in Toronto, ON. Dr. Habsha received her Diploma in Prosthodontics and Master of Science degree, both from the University of Toronto. She is a Fellow of the Royal College of Dentists of Canada (RCDC) and is an examiner and past Section Head for the Oral Examination in Prosthodontics for the RCDC. Dr. Habsha is an Adjunct Assistant Professor at the Department of Dentistry, Eastman Institute for Oral Health at the University of Rochester Medical Center. She has served as an Assistant Professor at the University of Toronto and currently instructs at the graduate level in Prosthodontics at U of T. Dr. Habsha is a Professor at George Brown College of Applied Arts and Technology and is the On-staff Prosthodontist at MedCan clinic in Toronto. She holds an appointment as Staff Prosthodontist at Mount Sinai Hospital where she instructs the dental residents and is involved in various clinical research projects. Dr. Habsha is an Associate Fellow of the Academy of Prosthodontics and Greater New York Academy of Prosthodontics, a Fellow of The Pierre Fauchard Academy and holds memberships in numerous Prosthodontic organizations and societies. She is a trailblazer and founder of Women in Dentistry: Work.Life.Balance, an organization dedicated to educating, networking and empowering women in the dental field. Dr. Habsha lectures both nationally and internationally on various Prosthodontic topics and maintains a private practice limited to Prosthodontics and Implant Dentistry in Toronto. For more information and to connect with Dr. Habsha, check out her social media profiles: Instagram: @effiehabsha, @womensdentistry Website: womenindentistry.ca If you made it all the way down here, hit a like and share a comment. Until next time, Peace out peeps! ✌️ _______________________________________  

Welcome to the 157th episode of the Tooth or Dare Podcast with Irene Iancu (@toothlife.irene) and this week's guest Dr. Effrat (Effie) Habsha (@effiehabsha).  Do you love your smile? Dr. Habsha's goal is to make sure her patients do. As a prosthodontist, every day can be a new challenge. Figuring out how to bring out the best smile in everyone can be difficult but very rewarding - and sometimes, a few small modifications can go a long way. Listen to the full episode to learn how Dr. Habsha fell in love with her specialty, how digital technology has improved the smile design process, and whether or not implants need the same attention as real teeth… The answer may surprise you! Effrat (Effie) Habsha, BSc, DDS, Dip. Prostho., MSc, FRCDC Dr. Effie Habsha is the Founder of Women in Dentistry: Work. Life. Balance.  She received her Bachelor of Science degree and earned her DDS degree from the University of Toronto. Upon graduation, she completed a one-year General Practice Residency at Mount Sinai Hospital in Toronto, ON. Dr. Habsha received her Diploma in Prosthodontics and Master of Science degree, both from the University of Toronto. She is a Fellow of the Royal College of Dentists of Canada (RCDC) and is an examiner and past Section Head for the Oral Examination in Prosthodontics for the RCDC. Dr. Habsha is an Adjunct Assistant Professor at the Department of Dentistry, Eastman Institute for Oral Health at the University of Rochester Medical Center. She has served as an Assistant Professor at the University of Toronto and currently instructs at the graduate level in Prosthodontics at U of T. Dr. Habsha is a Professor at George Brown College of Applied Arts and Technology and is the On-staff Prosthodontist at MedCan clinic in Toronto. She holds an appointment as Staff Prosthodontist at Mount Sinai Hospital where she instructs the dental residents and is involved in various clinical research projects. Dr. Habsha is an Associate Fellow of the Academy of Prosthodontics and Greater New York Academy of Prosthodontics, a Fellow of The Pierre Fauchard Academy and holds memberships in numerous Prosthodontic organizations and societies. She is a trailblazer and founder of Women in Dentistry: Work.Life.Balance, an organization dedicated to educating, networking and empowering women in the dental field. Dr. Habsha lectures both nationally and internationally on various Prosthodontic topics and maintains a private practice limited to Prosthodontics and Implant Dentistry in Toronto. For more information and to connect with Dr. Habsha, check out her social media profiles: Instagram: @effiehabsha, @womensdentistry Website: womenindentistry.ca If you made it all the way down here, hit a like and share a comment. Until next time, Peace out peeps! ✌️ _______________________________________  

Jaw pain, headaches, and facial pain are all common and can have a profound effect on our quality of life. Lucky for us, we have an esteemed guest speaker on the show today to break these topics down and help us understand how we can overcome this pain.Donald R. Tanenbaum, DDS, MPH, graduated from the University of Pennsylvania in 1978 and then received his DDS degree from Columbia University School of Dental Medicine, and his MPH degree from Columbia University School of Public Health in 1982. He has been practicing for over 40 years, providing guidance and care to patients with temporomandibular problems, facial pain, headaches and sleep related breathing disorders. Today he reviews some of the causes and treatments for these issues and explains their biopsychosocial nature. He also discusses the importance of identifying habits that can perpetuate pain and stop or modify them. He touches on bite plates, injections, PT, posture and ergonomics as all ways to alleviate pain.Dr. Tanenbaum has co-authored a book for the public entitled, ‘Dr, Why Does My Face Still Ache?” and continues to give lectures to dental students and residents, medical grand rounds and to numerous dental societies and study clubs. Dr. Tanenbaum currently holds several positions, including: Clinical Assistant Professor at the School of Dental Medicine at the State University of New York in Stony Brook where he is the Director of the Orofacial Pain Course given to the third year dental students.  He is also the Section Head of the Division of OrofacialPain/TMD/Sleep Medicine in the Northwell Health Department of Dental Medicine at the Long Island Jewish Medical Center; and Clinical Assistant Professor, Hofstra Northwell School of Medicine. Dr. Tanenbaum is a Diplomate of the American Board of Orofacial Pain, a Fellow of the American Academy of Orofacial Pain, and a past President of the American Academy of Orofacial Pain  Dr Tanenbaum currently maintains private practices in New York City and Long Island limited to the diagnosis and management of orofacial pain, temporomandibular problems and sleep related breathing disorders.Connect with him:www.nytmj.com

Research has shown that homicide is the second-leading cause of pregnancy related-deaths. This episode sheds light on a troubling rate of homicides involving the pregnant and postpartum population in the United States, with a particular spike in 2020. Dr. Veronica Gillispie-Bell, a board-certified OBGYN, joins the discussion to unpack the findings of her research. Some of those key findings showcase the disproportionate impact on Black women and girls, the prevalence of firearms in these homicides, and the alarming fact that pregnant and postpartum women face a 35% greater risk of homicide than their non-pregnant counterparts. Also touched upon is the potential role of intimate partner violence and why better reporting can result in better outcomes for all. Guest Expert: Dr. Veronica Gillispie-Bell, Board Certified OBGYN, Section Head of Women's Services at Oschner Medical Center, Director for the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review Additional Research: PAMR report Louisiana Perinatal Quality Collaborative CDC Hear HER Campaign

Over the last decade, we've watched childhood obesity emerge as a major health concern, taking over news stories and social media posts worldwide. The evaluation and treatment of children with obesity has evolved, and how we handle these diagnoses today is different than in years past. What's important to emphasize is that obesity is a chronic disease, and the medical community needs to treat it as such. To learn more about this important topic and highlight an impressive woman in medicine, we are joined by Ihuoma Eneli, MD. She is the Section Head of Nutrition at Children's Hospital Colorado and a visiting professor of pediatrics at the University of Colorado School of Medicine. She is an internationally recognized expert on pediatric obesity and serves in leadership and advisory roles for many organizations. Some highlights from this episode include: A discussion of the new AAP obesity guidelines  Genetics and how clinicians can reframe their understanding of obesity  Suggestions for motivational interviewing with patients and families  Treatment options that are available to patient-families  The stigma around fault versus genetics  New drugs and their future impact  For more information on Children's Colorado, visit: childrenscolorado.org.    

Weeds are a constant fact of a gardener's life. As our guest, Toni DiTommaso, says we can count on three things in life: death, taxes, and weeds. But if it weren't for weeds, the world would have less topsoil than it has now, and humanity might have suffered mass starvation by now. Why? Because the plants we call weeds do a vital job in ecosystems: they quickly establish in, protect, and restore soil that has been left exposed by natural and human-caused disturbances. That said, weeds, in addition to being a nuisance, cause more yield loss worldwide and add more to farms' production costs than insect pests, crop pathogens, root-feeding nematodes, or warm-blooded pests (rodents, birds, deer, etc.). So perhaps, we should start this discussion with a definition. What exactly is a ‘weed'? The Oxford Dictionary defines a weed as a wild plant growing where it is not wanted and in competition with cultivated plants. Similarly, the Miriam-Webster dictionary describes it as a plant that is not valued where it is growing and is usually of vigorous growth. Penn State Extension tells us that weeds compete with other plants for nutrients, water, and light, as well as potentially harbor diseases and pests. Simply put, a weed is a plant ‘out of place'. Plants that are characterized as weeds can reproduce via seeds, rhizomes, cuttings or runners. Their seeds are typically plentiful and tiny which can disperse easily and/or remain dormant for many years. They also can grow in less-than-ideal environments, soils, and conditions. As any gardener knows, they tend to grow fast and can outcompete other plants. Weed management can also be frustrating as some of these plants can break off and re-sprout or self-pollinate if pulled out. The best place to begin is to learn how to identify weeds. In this episode, we are fortunate to hear from Antonio (Toni) DiTommaso, Professor and Section Head, School of Integrative Plant Science Soil and Crop Sciences Section at Cornell University's College of Agriculture and Life Sciences (CALS). The focus of his research is to gain a more in depth understanding of the basic biological and ecological principles governing weeds to find safe, effective, sustainable and economically viable weed management strategies. In addition to his teaching and research duties, he is also a co-author of the book, Weeds of the Northeast.The fully updated second edition provides detailed illustrations for easy identification of more than 500 common and economically important weeds in the Northeast including New York.A practical guide, it includes a dichotomous key as well as descriptions and photos of floral and vegetative characteristics, giving anyone who works with plants the ability to identify weeds before they flower. Comparison tables make it easy to differentiate between many closely related and similar species. Listen to this episode of Nature Calls: Conversations from the Hudson Valley, to learn more about Toni DiTommaso and weeds.This will be of interest to home gardeners, landscape managers, as well as pest management specialists. Hosts: Tim Kennelty and Jean Thomas Guest: Antonio DiTommaso Photo by: Cornell University CALS Production Support: Linda Aydlett, Deven Connelly, Teresa Golden, Xandra Powers, Annie Scibienski Resources

Guest: Martin B. Brodsky, Ph.D., Sc.M., CCC-SLP, F-ASHA - In this episode, Michelle is joined by none other than THE Martin B. Brodsky, Ph.D., Sc.M., CCC-SLP, F-ASHA, Section Head for Speech-Language Pathology in the Integrated Surgical Institute at Cleveland Clinic and Adjunct Associate Professor of Physical Medicine and Rehabilitation and Pulmonary and Critical Care Medicine at Johns Hopkins University. Martin opens this hour, sharing his journey into critical care for adults and the role of mentors. Then Martin and Michelle deep dive into ICU delirium, discussing potential etiologies that could trigger it and how it could impact a patient's cognition and deglutition. The hour wraps with a discussion on the speech-language pathologist's role and responsibility to support patients across the life continuum with respect to the ethical timing of intervention. If you are an SLP who treats across the life continuum or are interested in working with adults, this is the episode for you!

Speaking with us on Well Said is Dr. Banu Aygun, a Pediatric Hematologist, Oncologist and Professor of Pediatrics at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. She also serves as the Associate Chief of Hematology at Cohen's Children's Hospital and the Section Head of Sickle Cell Disease at Cohen Children's Medical Center. She will be joined by her patient, Juan Carlos Benitez who was part of a landmark clinical trial that led to the FDA approval of a gene therapy for SSD. They will be discussing the ins and outs of SSD as well as the many new promising treatments including recent clinical trials focusing on gene editing.

Learning Objectives:Promoting evidence-based cancer screening and prevention strategiesDiscerning between patients with average, below average, and above average riskRecognizing the differences between imaging modalities available for breast cancer screeningSpeakers:Jessica Croley, MD, Breast Medical Oncologist, OCI Breast Clinical Council LeadPeter Eby, MD, FSBI, FACR, Section Head of Breast Imaging, Virginia Mason Medical CenterJamie Hui, MD, Radiologist in Breast Imaging, Virginia Mason Franciscan HealthPanelists:Peter Emanuel, MD, Vice President of Oncology, CommonSpirit Health Oncology Clinical Institute

We have a special edition of The Word on Medicine for you this Saturday. Our program discusses Keeping Your Doctors Healthy: a topic that often does not get the attention it needs. As you all know, doctors make the worst patients! In order to keep all of you healthy, we need a well-run health system and healthy doctors and nurses. Unfortunately, doctors may occasionally not take good care of themselves, something we will dive into in today's program with our special guest Dr. Carrie Cunningham, Associate Professor of Surgery at Harvard Medical School, and Section Head of Endocrine Surgery at Massachusetts General Hospital. Dr. Cunningham will be joined by our current administrative Chief Residents, Drs. Colleen Flanagan and Sam Thalji, our Residency Program Director, Dr. Rana Higgins, Dr. Dan Holena Professor of Surgery, and Dr. Alicia Pilarski, Chief Well-Being Officer at Froedtert and MCW. Please join us for this unique program as The Word on Medicine explores rarely discussed topics in health care once again.

The following question refers to Section 7.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Cleveland Clinic internal medicine resident and CardioNerds Intern Akiva Rosenzveig, answered first by UPMC Harrisburg cardiology fellow and CardioNerds Academy House Faculty Leader Dr. Ahmed Ghoneem, and then by expert faculty Dr. Randall Starling. Dr. Starling is Professor of Medicine and an advanced heart failure and transplant cardiologist at the Cleveland Clinic where he was formerly the Section Head of Heart Failure, Vice Chairman of Cardiovascular Medicine, and member of the Cleveland Clinic Board of Governors. Dr. Starling is also Past President of the Heart Failure Society of America in 2018-2019. Dr. Staring was among the earliest CardioNerds faculty guests and has since been a valuable source of mentorship and inspiration. Dr. Starling's sponsorship and support was instrumental in the origins of the CardioNerds Clinical Trials Program.  The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #27 Which of the following sentences regarding diuretics in the management of heart failure is correct? A In HF patients with minimal congestive symptoms, medical management with diuretics alone is sufficient to improve outcomes. B Prescribing a loop diuretic on discharge after a HF hospitalization may improve short term mortality and HF rehospitalization rates. C The combination of thiazide (or thiazide-like) diuretics with loop diuretics is preferred to higher doses of loop diuretics in patients with HF and congestive symptoms. D The maximum daily dose of furosemide is 300 mg. Answer #27 Explanation Choice B in correct. The guidelines give a Class 1 recommendation for diuretics in HF patients who have fluid retention to relieve congestion, improve symptoms, and prevent worsening heart failure. Recent data from the non-randomized OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry revealed reduced 30-day all-cause mortality and hospitalizations for HF with diuretic use compared with no diuretic use after hospital discharge for HF. Choice A is incorrect. With the exception of mineralocorticoid receptor antagonists (MRAs), the effects of diuretics on morbidity and mortality are uncertain. As such, diuretics should not be used in isolation, but always combined with other GDMT for HF that reduce hospitalizations and prolong survival. Choice C is incorrect. The use of a thiazide or thiazide-like diuretic (e.g., metolazone) in combination with a loop diuretic inhibits compensatory distal tubular sodium reabsorption, leading to enhanced natriuresis. In a propensity-score matched analysis in patients with hospitalized HF, the addition of metolazone to loop diuretics was found to increase the risk for hypokalemia, hyponatremia, worsening renal function, and mortality, whereas use of higher doses of loop diuretics was not found to adversely affect survival. The guidelines recommend that the addition of a thiazide (e.g., metolazone) to treatment with a loop diuretic should be reserved for patients who do not respond to moderate- or high-dose loop diuretics to minimize electrolyte abnormalities (Class...

Join us for an enlightening conversation with the esteemed Tibetan Medicine expert, Dr. Leslie Blackhall. Currently the Section Head for Palliative Care at the University of Virginia School of Medicine, Dr. Blackhall is a nationally recognized expert with pioneering work in bioethics, spirituality and medicine, and palliative care. Tibetan Medicine is an intricate practice that blends herbalism, spirituality, and holistic well-being. This ancient system was developed in Tibet and is based on Buddhist philosophy. On this episode, Dr. Blackhall sheds light on its core principles and their significance in the modern world including the interplay between mind, body, and spirit. Drs. Weil, Maizes, and Blackhall discuss how Tibetan Medicine practices align with the whole-person view of health and how they can contribute to a more harmonious life. This conversation promises to broaden your perspectives on what it means to live well.

Heinz-Josef Lenz, MD, FACP, is a Professor of Medicine and Preventive Medicine, J. Terrence Lanni Chair in Cancer Research, Section Head of GI Oncology and Co-Director of the Colorectal Center at the University of Southern California. He also serves as the Deputy Director for Research at USC Norris Comprehensive Cancer Center. Dr. Lenz is a physician-scientist known for his work on the pharmacogenomics of GI cancers. He is a member of several professional societies, including the AACR & AGA and serves on the National Advisory Board of a number of professional organizations. Dr. Lenz is the Co-Chair of the GI Committee and Correlative Science Committee for SWOG. He has published over 450 peer reviewed manuscripts. He has been listed in the Best Doctors' database since 2003. “You need to be very resilient and always dream big. Don't limit yourself with boundaries.” Why is resilience so important for a physician? Early in his career, Dr. Lenz was told that he cannot make it as a researcher by his superior; the only response Dr. Lenz had was, "I will show you." Looking ahead a few years, Dr. Lenz is now a highly renowned researcher and clinician with many accolades to his name. Join us on another episode of Medicine Mentors where we discuss core values a physician must exhibit, the success factor of effective mentors, and what it means to be an influential physician-leader with Dr. Heinz-Josef Lenz. Pearls of Wisdom:   1. Learn to be open-minded. Always be relentless and resilient in your pursuits. Explore different diversities with the right mindset and maximize your potential. 2. A successful mentor can instill a sense of accountability in their mentees, making sure they know that great things are expected of them. 3. A leader's job is to maximize the existing potential of the group and eliminate the gaps and weak links by recognizing talent and assigning appropriate roles.

The Osteosarcoma Institute (OSI) is currently supporting two clinical trials and seven laboratory research projects for osteosarcoma. In this OsteoBites episode, you will meet Lee J. Helman, MD, Director of the OSI and Chand Khanna, DVM, PhD, Chair of the OSI's Strategic Advisory Board. Dr. Helman and Dr. Khanna will provide an overview of the OSI's osteosarcoma research portfolio and explain how the OSI identifies promising osteosarcoma research projects. Lee J. Helman, MD has been studying the biology and caring for pediatric patients with sarcomas for over thirty years. Dr. Helman completed his post-doctoral training at the National Cancer Institute (NCI). He then became Head of the Molecular Oncology Section, Pediatric Oncology Branch, NCI, in 1993. He served as Chief of the Pediatric Oncology Branch from 1997-2007 and served as Scientific Director for Clinical Research in the Center for Cancer Research, National Cancer Institute from 2007 to 2016. He joined Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) in 2017 as the Section Head of Basic and Translational Research within the Cancer and Blood Disease Institute (CBDI) and the Division of Hematology, Oncology and Blood and Marrow Transplantation. He remains an adjunct professor at CHLA. He has also trained many investigators in the field of pediatric sarcomas over the course of his career. He is currently focusing on improving outcomes in osteosarcoma as the Director of the Osteosarcoma Institute. Chand Khanna, DVM, PhD is Chief Science Officer with Ethos Veterinary Health, and President of Ethos Discovery(501c3), its incubator of scientific innovation. His responsibility at Ethos Discovery is to develop innovations in the form of novel diagnostics and therapeutics for both human and animal patients afflicted with similar complex disease conditions (i.e., osteosarcoma; so called Comparative Oncology). Dr. Khanna is a veterinary oncologist and both osteosarcoma and metastasis biologist, who has worked in this scientific field for over 20 years, most notably as a senior investigator of the Tumor and Metastasis Biology section of the Pediatric Oncology Branch at the National Cancer Institute and founding Director of its Comparative Oncology Program. Dr. Khanna's research career has focused on improving the understanding of the biology of metastasis in osteosarcoma and the use of a cross species (mouse, dog, human), Comparative and translational approach to develop novel therapeutics for osteosarcoma metastasis. He serves as the Chair of the Osteosarcoma Institute's Strategic Advisory Board. --- What We Do at MIB Agents: PROGRAMS: End-of-Life MISSIONS Gamer Agents Agent Writers Prayer Agents Healing Hearts - Bereaved Parent and Sibling Support Ambassador Agents - Peer Support Warrior Mail Young Adult Survivorship Support Group EDUCATION for physicians, researchers and families: OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: Annual MIB FACTOR Research Conference Funding multiple $100,000 and $50,000 grants annually for OS research MIB Testing & Research Directory The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. https://www.mibagents.org​ Help support MIB Agents, Donate here https://give-usa.keela.co/embed/YAipuSaWxHPJP7RCJ SUBSCRIBE for all the Osteosarcoma Intel

On this episode of the Butts and Guts podcast, Michael Rosen, MD, shares everything you need to know about hernia surgeries, along with the basics of abdominal core health. Listen to learn more about these topics from Dr. Rosen, who is a professor of surgery, the Section Head of the Abdominal Wall Reconstruction Team, and the DDSI Surgical Operations Vice Chair in the Department of General Surgery, all at Cleveland Clinic.

Section Head of Head and Neck Cancer Eric Lamarre, MD, joins our podcast to discuss featured research by our staff at the 2023 American Head and Neck Society 11th International Conference on Head and Neck Cancer. Dr. Lamarre also discusses new and upcoming clinical trials, along with his leadership in our medical student research program.

In this week's episode we are joined by Dr. Georgia Malandraki, Professor in the Department of Speech Language and Hearing Sciences at Purdue University and Faculty Associate in the Center on Aging and the Lifecycle, along with Dr. Martin Brodsky, Section Head of Speech-Language Pathology here in our Head and Neck Institute. Listen as we discuss highlights from the World Dysphagia Summit.

Today we have Dr. Brian Cole, an orthopedic surgeon who specializes in cartilage restoration, orthobiologics, and advanced surgical techniques for the treatment of knee, elbow, and shoulder injuries. He is the team physician for the NBA's Chicago Bulls and the co-team physician for the Chicago White Sox. He also is the host of the Sports Medicine Weekly Podcast. Brian practices orthopedic sports medicine at Midwest Orthopaedics. He also is a professor of Orthopaedics, Anatomy and Cell Biology at Rush University Medical Center in Chicago. He is Managing Partner of Midwest Orthopaedics and is the department's Associate Chairman and the Section Head of the Cartilage Research and Restoration Center. In addition to this work, he also serves as the Chairman of Surgery at Rush Oak Park Hospital. In today's interview, we talk to Brian about his cutting-edge research into ways to treat knee, shoulder, and elbow injuries.  Brian shares his novel approach to dealing with ACL tears, one of the most common sports injuries, and his investigations of methods to enhance the healing and recovery time following ACL reconstructions. He also talks about new advances in minimally invasive surgical techniques for many common injuries.  We have a particularly interesting conversation with Brian about exciting developments in the use of stem-cell treatments as well as the use of bone marrow aspirate to treat injuries. Show notes: [00:03:53] Marcas opens the interview mentioning that Brian was in the eighth grade when he fell in love with a popular sit-com from the 1970s,  “The Bob Newhart Show.” Marcas asks Brain what he loved about the show and what impact it had on him. [00:05:07] Brian enrolled in the University of Illinois after graduating from high school. Marcas asks Brian if knew he wanted to major in biology and psychology when he arrived on campus. [00:05:58] Ken mentions that after Brian's undergrad, he travelled upstate to the University of Chicago, where he earned an MD and an MBA. Ken asks what led Brian to pursue both an MD and MBA. [00:09:52] Ken explains that after the University of Chicago, Brian moved to New York City for an orthopaedic research fellowship in metabolic bone disease at the Hospital for Special Surgery. Brian also decided to do his residency there as well. Ken asks how that came about. [00:11:31] Marcas mentions that after Brian finished his fellowship and residency, he went to the University of Pittsburgh for a sports medicine fellowship. Marcas asks what led Brian there and what drove his interest in sports medicine. [00:13:10] Marcas asks Brian about a fortuitous phone call he received when he was a fourth-year resident. [00:14:34] Ken explains that Midwest Orthopaedics is one of the nation's most respected private orthopaedic practices.  Ken notes that through a partnership with Rush University Medical Center, Midwest has developed a national reputation as a leader in sports medicine; hip, knee, spine, and cartilage restoration; as well as shoulder care and pain management. Rush also is an academic medical center that includes a 671-bed hospital and is a center for basic and clinical research. Ken asks Brian to describe the scope of the work that goes on at Midwest and Rush. [00:17:20] Marcas comments that Brian is also the head team physician for the Chicago Bulls and the co-team physician for the Chicago White Sox, and asks Brian to describe some of the work that he does in that capacity. [00:20:09] Marcas explains that Brian treats a wide range of patients with injuries and pain, from athletes to non-athletes, and from children to senior citizens, and that he has performed more than 20,000 surgeries over the course of his career. Marcas asks Brian to give a sense of the patients he sees and what his average day at the office is like. [00:24:00] Ken points out that Brian is known for focusing on treating the patient and not the x-ray or MRI.

While Cleveland Clinic is a large, academic medical institution with many specialty services that patients travel the world to receive, at the same time we're also here to care for our community in northeast Ohio and provide more traditional care to patients as well. Kyra Osborne, MD, Section Head of Comprehensive Otolaryngology, joins to discuss.

OSI Connect is the Osteosarcoma Institute's free, easy-to-use resource for patients who have been diagnosed with osteosarcoma or suffered a relapse after initial treatment. In this OsteoBites episode, you will meet Lee J. Helman, MD, Director of the OSI and Chelsey Blanks, OSI Connect Administrator. You will learn how OSI Connect works and examples of how the program has helped more than 70 patients since its launch in 2019. Lee J. Helman, MD has been studying the biology and caring for pediatric patients with sarcomas for over thirty years. Dr. Helman completed his post-doctoral training at the National Cancer Institute (NCI). He then became Head of the Molecular Oncology Section, Pediatric Oncology Branch, NCI, in 1993. He served as Chief of the Pediatric Oncology Branch from 1997-2007 and served as Scientific Director for Clinical Research in the Center for Cancer Research, National Cancer Institute from 2007 to 2016. He joined Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) in 2017 as the Section Head of Basic and Translational Research within the Cancer and Blood Disease Institute (CBDI) and the Division of Hematology, Oncology and Blood and Marrow Transplantation. He remains an adjunct professor at CHLA. He has also trained many investigators in the field of pediatric sarcomas over the course of his career. He is currently focusing on improving outcomes in osteosarcoma as the Director of the Osteosarcoma Institute. As the Osteosarcoma Institute Operations Manager, Chelsey Blanks schedules meetings for the board, oversees various operational aspects of the organization (including HR, IT, and office management), facilitates the grant cycle, and manages OSI Connect (formerly OSI Hotline) that offers free expert advice for osteosarcoma patients and families no matter where they are in their journey. Although Chelsey is Texan through and through, she spent six years living in Southern California and was thrilled to return to the homeland with her husband, Jordan, at the end of 2019. Chelsey obtained her undergraduate degree from the University of North Texas, where she studied Sociology, Philosophy, and Dance. Previously, she had an insurance and financial services career and was an Executive Assistant for her church in Orange County, California. --- What We Do at MIB Agents: PROGRAMS: End-of-Life MISSIONS Gamer Agents Agent Writers Prayer Agents Healing Hearts - Bereaved Parent and Sibling Support Ambassador Agents - Peer Support Warrior Mail Young Adult Survivorship Support Group EDUCATION for physicians, researchers and families: OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: Annual MIB FACTOR Research Conference Funding multiple $100,000 and $50,000 grants annually for OS research MIB Testing & Research Directory The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. https://www.mibagents.org​ Help support MIB Agents, Donate here https://give-usa.keela.co/embed/YAipuSaWxHPJP7RCJ SUBSCRIBE for all the Osteosarcoma Intel

Joining Brian and myself in our virtual studio we are delighted to speak to Professor Edward Cooper, Section Head of Small Animal Emergency and Critical Care at The Ohio State University. I thought we’d continue the theme of the last podcast on feline urethral obstruction and speak to an international authority on the subject, who has been trying to answer some fundamental questions about this topic. He kindly returned my email and spoke to us, despite technical issues he was incredibly patient. Prof Cooper is clearly passionate about this topic and it was great to talk, we hope that you enjoy. Link to Prof Cooper’s bio: https://vet.osu.edu/cooper-edward  Some references: https://pubmed.ncbi.nlm.nih.gov/21118011/ https://pubmed.ncbi.nlm.nih.gov/31250535/ https://pubmed.ncbi.nlm.nih.gov/31840942/ https://pubmed.ncbi.nlm.nih.gov/36779411/ https://pubmed.ncbi.nlm.nih.gov/33620246/ To Cite this podcast as: Dom Barfield. RVC Clinical Podcast 138 Feline Urethral Obstruction with Edward Cooper. Published on April 28 2023 If you have any comments about this podcast, please get in touch: email dbarfield@rvc.ac.uk; or follow us on instagram @rvcclinicalpodcast. We would greatly appreciate your time to rate us on Apple podcast, podbean or Acast and kindly write us a review.

Peripheral Artery Disease (PAD) is a chronic circulatory condition, which if not treated, can lead to limb amputations. PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minority communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa, and Jon Quatromoni share their thoughts as experts in their fields. Part 2 highlights medications, interventions and the benefits of these various specialties collaborating to ensure patients receive the best possible care.

PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minorities communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa and Jon Quatromoni share their insights as experts in their fields. Part 2 highlights medications, interventions and the benefits of these various specialties collaborating to ensure patients receive the best possible care.

Peripheral Artery Disease (PAD) is a chronic circulatory condition, which, if not treated, can lead to limb amputations. PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minority communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa, and Jon Quatromoni share their thoughts as experts in their fields. Part 1 highlights screening and testing, diagnosis and when to operate.

PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minorities communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa, and Jon Quatromoni share their insights as experts in their fields. Part 1 highlights screening and testing, supervised exercise therapy, and wounds.

Raj Sindwani, MD, Vice Chair and Section Head of Rhinology in our Head & Neck Institute, joins to discuss new research presented at the North American Skull Base Society annual meeting. Dr. Sindwani also shares how these newly published findings are innovating the approach of our skull base surgeons.

My guest today is Dr. April Elliott  - an award-winning medical doctor, executive coach, consultant, writer, and speaker. Dr. Elliott has been the Section Head (and program founder) of Adolescent and Emerging Adult health in a leading Canadian hospital for the past 21 years. And last, but definitely not least, I am proud to say she is one of my oldest (in years not age) and dearest friends.During our conversation we cover everything from working with adolescents to working on your personal brand.Other topics include:Why everyone should live out their passionThe value of emotional regulationHow to set a goal and make it happenHow to figure out your core valuesAnd why it's ok not to be everyone's cup of teaI hope you enjoy the conversation and learn a few things to help you with your branding.

Martin Brodsky, PhD, ScM, CCC-SLP, new Section Head of Speech Language Pathology, joins to discuss the ever-changing field of speech language pathology (SLP). Dr. Brodsky discusses research that he's participating in, as well as his goals for multidisciplinary SLP care at Cleveland Clinic.

The following question refers to Section 7.4 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by New York Medical College medical student and CardioNerds Intern Akiva Rosenzveig, answered first by Cornell cardiology fellow and CardioNerds Ambassador Dr. Jaya Kanduri, and then by expert faculty Dr. Randall Starling.Dr. Starling is Professor of Medicine and an advanced heart failure and transplant cardiologist at the Cleveland Clinic where he was formerly the Section Head of Heart Failure, Vice Chairman of Cardiovascular Medicine, and member of the Cleveland Clinic Board of Governors. Dr. Starling is also Past President of the Heart Failure Society of America in 2018-2019. Dr. Staring was among the earliest CardioNerds faculty guests and has since been a valuable source of mentorship and inspiration. Dr. Starling's sponsorship and support was instrumental in the origins of the CardioNerds Clinical Trials Program.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #6 Mr. D is a 50-year-old man who presented two months ago with palpations and new onset bilateral lower extremity swelling. Review of systems was negative for prior syncope. On transthoracic echocardiogram, he had an LVEF of 40% with moderate RV dilation and dysfunction. EKG showed inverted T-waves and low-amplitude signals just after the QRS in leads V1-V3. Ambulatory monitor revealed several episodes non-sustained ventricular tachycardia with a LBBB morphology. He was initiated on GDMT and underwent genetic testing that revealed 2 desmosomal gene variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC). Is the following statement true or false? “ICD implantation is inappropriate at this time because his LVEF is >35%” True   False   Answer #6 Explanation This statement is False. ICD implantation is reasonable to decrease sudden death in patients with genetic arrhythmogenic cardiomyopathy with high-risk features of sudden death who have an LVEF ≤45% (Class 2a, LOE B-NR). While the HF guidelines do not define high-risk features of sudden death, the 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy identify major and minor risk factors for ventricular arrhythmias as follows: Major criteria: NSVT, inducibility of VT during EPS, LVEF ≤ 49%. Minor criteria: male sex, >1000 premature ventricular contractions (PVCs)/24 hours, RV dysfunction, proband status, 2 or more desmosomal variants. According to the HRS statement, high risk is defined as having either three major, two major and two minor, or one major and four minor risk factors for a class 2a recommendation for primary prevention ICD in this population (LOE B-NR). Based on these criteria, our patient has 2 major risk factors (NSVT & LVEF ≤ 49%), and 3 minor risk factors (male sex, RV dysfunction, and 2 desmosomal variants) for ventricular arrhythmias. Therefore, ICD implantation for primary prevention of sudden cardiac death is reasonable. Decisions around ICD implantation for primary prevention remain challenging and depend on estimated risk for SCD, co-morbidities, and patient preferences, and so should be guided by shared decision making weighing the possible benefits against the risks,

This month we're diving into the world of water quality monitoring. The "how" of achieving clean water can be messy – but crucial – work. Monitoring helps guide decisions surrounding the implementation of the rest of the Clean Water Act. We'll explore the elements of successful water quality monitoring programs, where these programs are heading, and hear a couple success stories along the way.   About our guests:   Monty Porter – Monty has worked for the Oklahoma Water Resource Board for the past 25 years. Currently, he is the Assistant Division Chief of Water Quality Programs and Section Head of Data Science and Management.   Kellie Merrell – Kellie has worked for the Vermont Department of Environmental Conservation since 2001. She is an Aquatic Ecologist who monitors the status and trends of Vermont's inland lakes.   Follow us @cleanwaterpod on Twitter to keep up with the latest podcast news! Learn more about NEIWPCC at neiwpcc.org

In this episode, Siri Khalsa and I co-host a conversation with Marta Ferrari. Marta and Siri were classmate on the Fletcher School's GMAP programme in International Relations. Marta has an interesting background: advanced degree in physics, Master in international relations at the Fletcher School, management studies at the INSEAD Business School and recently completed the Visionary Leadership Programme at Ashoka. She started her career in an engineering company, worked for many years at the International Atomic Energy Agency in a number of technical and management positions. She was recently working in France, holding a director position in the nuclear industry before coming back to the IAEA a few months ago, as a Section Head in Operations in Safeguards.Recorded on 23 June 2022.Instagram: @at.the.coalfaceConnect with Marta Ferrari on LinkedIn at linkedin.com/in/marta-ferrari-08834071.Please subscribe to At the Coalface wherever you get your podcasts to receive a new episode every two weeks: Apple Podcasts  |  Spotify  |  Google PodcastsSupport the show

On this episode of BackTable OBGYN, we introduce our co-host Dr. Amy Park, the Section Head of Female Pelvic Medicine & Reconstructive Surgery at the Cleveland Clinic. She and Dr. Mark Hoffman raise awareness about the importance of surgeon ergonomics in preventing work-related musculoskeletal (MSK) injuries and optimizing career longevity. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/vpfOUm --- SHOW NOTES Dr. Park, a co-founder of the Society of Surgical Ergonomics, begins the episode by sharing her personal experience with a work-related shoulder injury and how it inspired her to prioritize surgeon ergonomics in her daily practice. She and Dr. Hoffman then encourage listeners to acknowledge the role of optimizing factors such as table height, body posture, and more in order to maximize the longevity of a surgeon's career and thus patient care. The co-hosts then cover pitfalls commonly identified in normal, open surgery (e.g. excessive neck flexion, truncal deviation, arm abduction) and laparoscopic surgery (e.g. body posture, monitor height). They transition to highlight possible resolutions to these pitfalls, including anti-fatigue mats, appropriate footwear, and proper posturing; ultimately addressing a need for further research in this aspect of medicine. Lastly, they cover the role of robotic surgery and the potential to either mitigate or worsen the risk for work-related MSK injuries. The episode wraps up with a call to bring awareness to the value of surgeon ergonomics and to proactively impart this knowledge onto trainees, as the overall goal for surgeons is likely to continue operating and impacting patient care. --- RESOURCES Epstein S, Sparer EH, Tran BN, et al. Prevalence of Work-Related Musculoskeletal Disorders Among Surgeons and Interventionalists: A Systematic Review and Meta-analysis. JAMA Surg. 2018;153(2):e174947. doi:10.1001/jamasurg.2017.4947 Society of Surgical Ergonomics: https://www.societyofsurgicalergonomics.org The FIRST Trial: http://www.thefirsttrial.org The SECOND Trial: http://www.thesecondtrial.org

PODCAST EPISODE "BATON UNCUT: HIV & the LGBTQ+ Community in the Philippines" • Season 3, Episode 34, Rated-21 • 69 Questions with Dr. Van Baton • Sponsored by Studio Historias, a dedicated production service for podcasts, radio, and other online shows. Go to about.studiohistorias.com to learn more. ABOUT THE GUEST Dr. Van Phillip Baton is a Medical Officer IV of the Department of Health Central Visayas Center for Health Development. He is currently designated as the Section Head of the Non-Communicable Disease Section and medical coordinator for a number of Communicable Diseases program working for the control and elimination various infectious diseases in coordination with the local government units, private sector, international funding agencies and non-government/civil society organizations in the region through technical assistance, monitoring and evaluation and logistics support. Dr. Baton is a firm believer in the role of data in shaping policies that will result in the efficient use limited resources and the role of epidemiology in finding practical solutions to public health problems in the age of epidemics. An advocate for the role of public health practitioners as guides for policy makers in creating better public health policies as we move towards universal health care through correct, proper and timely interpretation of data. ABOUT THE HOST ALPHECCA PERPETUA is a Filipino KBP-accredited radio broadcaster who executively produces podcast shows, radio programs, and small-stage live events. An undergraduate student for the Marine Biology degree program at the University of San Carlos in 2004, she shifted focus and specialization to radio presenting and audio production for both Contemporary-Hit and Rock Radio format treatments as well as live-events hosting starting late 2005. In 2008, she was among the chosen national top 80 participants for I-Witness's first docufest, an award-winning PH documentary TV show for GMA-7 News TV and GMA broadcast network. Today, she continues to develop and co-produce global TOP-100 podcast shows; including the seasonal Cebu-based Comedy Talk & Interviews, "Podcast Historias". DESCRIPTION Podcast Historias with @alpheccaperpetua • Presented/Hosted by Alphecca Perpetua • Arranged, Mixed, and Mastered by Alphecca Perpetua • Produced by Alphecca Perpetua & Brent Kohnan • Distributed by Studio Historias • about.studiohistorias.com • Cebu, Philippines 6000 • All Rights Reserved © 2022 DISCLAIMER The assumptions, views, opinions, and insinuations made by the host and guests do not reflect those of the show, the management, and the companies affiliated. A few information in this podcast episode may contain errors or inaccuracies; we do not make warranty as to the correctness or reliability of the content. If you think you own the rights to any of the material used and wish for the material not be used, please contact Studio Historias via email at askstudiohistorias@gmail.com.

This episode is brought to you by Heron Therapeutics. Please see full Prescribing Information, including Boxed Warning or visit www.ZYNRELEF.com. This episode is also brought to you by TrackableMed, grow your new patients. We have the one and only Dr. Brian Cole for this episode. Dr. Brian Cole is an orthopedic sports medicine surgeon at Midwest Orthopaedics at Rush and a Professor of Orthopaedics, Anatomy and Cell Biology at Rush University Medical Center. Dr. Cole is Managing Partner of Midwest Orthopaedics and is the Department's Associate Chairman and the Section Head of the Cartilage Research and Restoration Center. He's one of the most prolific and most influential sports medicine surgeons in the world. Dr. Cole is the head team physician for the Chicago Bulls and co-team physician for the Chicago White Sox. He's a member of every society for sports medicine orthopedics with a vast history of experience with a passion for education. This is one you're going to enjoy! Topics include:-He discusses what made him decide to become a physician and the influence going into orthopedics, including residency at the Hospital for Special Surgery at Cornell Medical Center, and a Sports Medicine fellowship at the University of Pittsburgh. Dr. Cole talks about how he made his way back to Chicago after fellowship at Midwest Orthopaedics at Rush and helping to build the cartilage restoration program. -He talks about the "private-demic" model of Rush, running it as a private practice with the benefits of being in the academic world. It's a private independent practice that fosters entrepreneurialism. -Dr. Cole has a passion for fellowships and can hear his devotion for the importance of mentorships. He discusses how it's essential to positively influence the next generation through fellowships. -We also hear about what is his work//life balance like with all of his responsibilities. Find out more about Dr. Brian Cole here. Also, find out more about Zynrelef here: ZYNRELEF utilizes a novel synergistic mechanism of action that combines bupivacaine with a low dose of meloxicam to overcome the challenges of the inflammatory process at the surgical site. ZYNRELEF is the first and only extended-release dual-acting local anesthetic™ (DALA™) and delivers 72 hours of postoperative pain relief via a single needle-free application. It has been clinically proven to better manage pain than standard of care bupivacaine HCl solution over 72 hours and to significantly reduce opioid utilization following surgery. -ZYNRELEF was initially approved by the FDA in May 2021 and in December 2021, the FDA approved an expansion of ZYNRELEF's indication. -Limitations of Use: Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures. WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS See full prescribing information for complete boxed warning. • Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use • ZYNRELEF is contraindicated in the setting of coronary artery bypass graft (CABG) surgery • NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events ZYNRELEF is contraindicated for: • Patients with a known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to any local anesthetic agent of the amide-type, NSAIDs,